Pancreatic Cancer Research

ResearcherTUM KlinikumActive in the last 2 years

Florian Scheufele

Matched on ORCID iD 0000-0002-7105-0895; OpenAlex author ID A5036637446. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 10

  1. Prognostic implications of superior mesenteric vein/portal vein resection and histologic venous invasion in BR/LA PDAC after neoadjuvant therapy. Last author DOI 10.1007/s00423-026-04145-9↗
  2. Surgical Perspectives on Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer. Last author DOI 10.3390/cancers18071131↗
  3. Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. Co-author DOI 10.1093/bjsopen/zrad125↗
  4. [Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer]. Co-author DOI 10.1007/s00104-019-01093-7↗
  5. Pancreatic cancer. First author DOI 10.21037/tgh.2019.12.15↗
  6. Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer. Co-author DOI 10.21037/tgh.2019.04.09↗
  7. Venous resection during pancreatectomy for pancreatic cancer: a systematic review. Co-author DOI 10.21037/tgh.2019.06.01↗
  8. Meta-analysis of the impact of neoadjuvant therapy on patterns of recurrence in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/bjs5.46↗
  9. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000002345↗
  10. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis. Co-author DOI 10.1016/j.suronc.2017.01.007↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Helmut Friess · 6 shared papers, 2017–2026 · strength 1.37
  2. İhsan Ekin Demir · 7 shared papers, 2017–2026 · strength 1.23
  3. Stephan Schorn · 5 shared papers, 2017–2024 · strength 0.51
  4. Guralp Onur Ceyhan · 5 shared papers, 2017–2024 · strength 0.51
  5. Helmut Frieß · 4 shared papers, 2018–2020 · strength 0.50
  6. Jingcheng Zhang · 1 shared paper, 2026 · strength 0.39
  7. J M. Zhang · 1 shared paper, 2026 · strength 0.33
  8. Lei Ren · 1 shared paper, 2026 · strength 0.33
  9. Rüdiger Göß · 2 shared papers, 2017–2024 · strength 0.25
  10. Alexander Muckenhuber · 1 shared paper, 2024 · strength 0.18
  11. Ilaria Pergolini · 1 shared paper, 2024 · strength 0.18
  12. Mustapha Adham · 1 shared paper, 2024 · strength 0.18
  13. Alexander Novotny · 1 shared paper, 2024 · strength 0.18
  14. Julie Périnel · 1 shared paper, 2024 · strength 0.18
  15. Okan Safak · 1 shared paper, 2024 · strength 0.18
  16. Elke Tieftrunk · 2 shared papers, 2017–2018 · strength 0.14
  17. Xiaobo Wang · 1 shared paper, 2019 · strength 0.11
  18. Wilko Weichert · 1 shared paper, 2018 · strength 0.07
  19. Anna Melissa Schlitter · 1 shared paper, 2018 · strength 0.07
  20. Iréne Esposito · 1 shared paper, 2018 · strength 0.07
  21. Carmen Mota Reyes · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.